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A 56-year-old man died suddenly at Yale-New Haven Hospital six weeks after experiencing a
myocardial infarct and subsequent leftventricle aneurysm formation. Clinical course, treatment,
radiologic data, and pathologic findings are examined. Differential diagnosis for this patient's
sudden demise include cardiac rupture with cardiac tamponade, extension of the myocardial
infarct, and massive pulmonary embolus, among others.
CLINICAL PATHOLOGICAL CONFERENCE
A 56-year-old man died suddenly at Yale-New Haven Hospital six weeks after
experiencing a myocardial infarct and subsequent left ventricle aneurysm formation.
History
A 56-year-old male executive was transferred from another hospital because of
recurrent cardiac arrhythmias. One year ago he developed substernal chest pain
typical of angina pectoris. A well-documented acute anterolateral myocardial infarc-
tion precipitated his admission to another hospital one month ago. He suffered several
prolonged episodes ofventricular tachycardia/fibrillation, which were unresponsive to
lidocaine, associated with grand mal seizures, and treated by cardioversion. He
subsequently developed right bundle branch block accompanied by left anterior
hemiblock. During an attempt to insert a pacemaker, he had anothergrand mal seizure
associated with ventricular tachycardia. In addition, he developed congestive heart
failure which initially responded to digoxin and diuretics, staphylococcal sepsis which
resulted from an infected line and was successfully treated with oxacillin, respiratory
failure which required transient ventilatory assistance, and a low-grade fever which
was attributed to Pronestyl.@
Episodes of ventricular tachycardia/fibrillation were eventually prevented by
tocainide. Ten days before transfer, the patient was treated with heparin followed by
Coumadin because of deep venous thrombosis of the left calf. Cardiac ultrasound
demonstrated a left ventricular aneurysm. Congestive heart failure became increas-
ingly difficult to manage, and attempts to reduce afterload with captopril, nitrates, or
nifedipine were frustrated by hypotension. Two days before transfer, he again
developed recurrent episodes ofventricular tachyarrhythmia whichcould becontrolled
only by continuous infusion ofbretylium.
457
Abbreviations: AMI: anterior wall myocardial infarction DVT: deep venous thrombosis GI: gastroin-
testinal IABP: intra-aortic balloon pump LAD: left anterior descending LAHB: left anterior hemi-
block MI: myocardial infarction RBBB: right bundle branch block
Address reprint requests to: Stuart D. Flynn, M.D., Dept. of Pathology, Yale University School of
Medicine, 310 Cedar Street, New Haven, CT 06510
Copyright e 1988 by The Yale Journal ofBiology and Medicine, Inc.
All rights ofreproduction in any form reserved.LEE ET AL.
Aside from 120 pack-years of cigarette smoking, there were no risk factors for
coronary artery disease, and the remainder ofthe history was not contributory.
At the time of transfer, the patient was alert but appeared ill. Except for jugular
venous distention, rales at both lung bases, and a third heart sound, no specific physical
findings were elicited by three examiners.
Chext X-ray showed only increased pulmonary congestion. The cardiac silhouette
was at the upper limits of normal. Electrocardiogram showed an extensive infarction
with Q waves in leads V2 through V6. Right bundle branch block (RBBB) and left
anterior hemiblock (LAHB) were also confirmed. Except for a hematocrit of 30
percent, complete blood count and electrolytes were normal except for Na, 127; BUN,
35; creatinine, 1.6, and a prothrombin time of 16.0/12.2.
Coumadin was stopped, and intravenous heparin was begun. Hyponatremia was
readily corrected by volume restriction. Electrophysiologic studies and aneurysmec-
tomy were considered, but 12 hours after admission the patient developed prolonged
ventricular tachycardia, persistent hypotension, and respiratory failure. He required
cardioversion, an intra-aortic balloon, tracheal intubation, a pacemaker, and hemody-
namic monitoring with a Swan-Ganz catheter. The following morning he had an
emergency cardiac catheterization, which showed a large left ventricular aneurysm
and 90 percent stenosis of the left anterior descending artery. Because of episodes of
ventricular tachycardia, Amiodarone was instituted, and the patient's condition
became stable. On the fifth hospital day, he was extubated and the intra-aortic balloon
was removed. Because he needed frequent repeated blood transfusions to maintain his
hematocrit above 30 percent, heparin was discontinued on the fifth hospital day.
Despite continuing congestive failure with an ejection fraction of only 9 percent, the
patient was able to walk to a limited extent and had no further episodes of
tachyarrhythmia while receiving Amiodarone. On the tenth hospital day, however, he
suddenly collapsed to the floor. Despite resuscitation for cardiopulmonary arrest, the
patient expired.
Clinical Discussion
DR. FORRESTERLEE (Assistant ProfessorofMedicine): In summary, a 56-year-old man
who sustained an anterior wall myocardial infarction (AMI) complicated by ventricu-
lar arrhythmias, aneurysm formation, and congestive heart failure, died suddenly in
the hospital after six weeks. I will first comment on his clinical course and then discuss
the differential diagnosis.
The patient was admitted to another hospital with an acute anterior infarction and
recurrent ventricular arrhythmias. Since we do not have many details from his early
hospital course, let me skip ahead in the protocol and note that a left ventricular
aneurysm was documented during a later echocardiographic examination. This finding
helps us to reconstruct some ofthe pathogenic processes which developed early during
his infarction and probably formed the basis for his subsequent cardiac complica-
tions.
Ventricular aneurysm formation following acute myocardial infarction has a
well-characterized temporal development. From serial echocardiographic and radio-
nuclide studies, we know that, during the first 48 hours following AMI, someventricles
undergo a process termed "infarct expansion." The left ventricle appears regionally
dilated with cavity deformation and myocardial thinning. These anatomic features are
typical of chronic ventricular aneurysms which all appear to begin as regional infarct
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expansion. Of particular relevance in this case, infarct expansion and cardiac rupture
have been very closely linked. Schuster and Bulkley found that 23 of24 autopsy heart
specimens with cardiac rupture had anatomic and pathological features of infarct
expansion [1].
Cardiac rupture is the second most common in-hospital cause of hemodynamic-
related deaths following acute infarction. It is, nonetheless, an uncommon event with
an incidence of less than 1 percent among transmural infarctions. On the other hand,
infarct expansion has been shown to develop in as many as 35 percent of acute
myocardial infarction (MI) patients. Though infrequently leading to cardiac rupture,
infarct expansion and aneurysm formation are clearly linked to a high incidence of
other cardiac-related complications, including arrhythmias, congestive heart failure,
and sudden death [2], all of which occurred in this patient. Thus infarct expansion
represents a cardinal event in this patient's course and must be considered in
formulating a differential diagnosis.
During his early hospitalization, there were other clinical events which might have
been a factor in his later death. A temporary transvenous pacemaker was placed for
bifascicular heart block. Among the several complications that can arise from
temporary pacemaker insertions are venous thrombosis and pacemaker rupture of
the right ventricle. This patient in fact developed a clinically documented left calf
thrombosis and was started on anticoagulant therapy. I would suspect that the tem-
porary pacemaker was a factor in initiating the venous thrombotic process. When
looked at by sensitive techniques, venous thrombosis can be documented following 40
percent of transvenous pacemaker insertions. Although these are usually clinically
silent, there are well-documented cases offatal thromboembolic complications related
to transvenous pacemakers [3].
In spite of the early complications of arrhythmias, severe congestive heart failure,
sepsis, and venous thrombosis, the patient was stabilized sufficiently to permit transfer
to Yale-New Haven Hospital after three weeks. Perhaps now it would be timely to
review his chest X-ray.
RadiologicStudies
DR. ANA M. SALAZAR (Resident in Radiology, Yale-New Haven Hospital): The
admission chest radiography is a portable film (Fig. 1). The heart is enlarged and has a
prominent left ventricular configuration. There is engorgement ofthe central vascula-
ture and haziness of the peripheral vascular markings, indicating interstitial pulmo-
nary edema. In this single projection, there is no definite evidence of a discrete left
ventricular aneurysm since the cardiac contour is smooth. A central venous catheter is
noted. There is no pneumothorax.
A follow-up film taken the next day demonstrates persistent congestive heart failure
(Fig. 2). The patient has been intubated and an intra-aortic balloon pump is visible in
good position. A Swan-Ganz catheter and a transvenous pacemaker have been inserted
via a femoral approach.
DR. LEE: Thus the chest X-ray confirms the congestive heart failure and cardiomegaly
that were apparent clinically. A temporary pacemaker inserted from a femoral
location is present on thesecond X-ray. Therefore, we must keep open the possibility of
a pacemaker-related complication. Soon after arrival, the patient again developed
intractable arrhythmias with hemodynamic deterioration and required cardiopulmo-
nary resuscitation. An intra-aortic balloon pump (IABP) was inserted. Although this
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FIG. 1. A portable chest
radiograph demonstrates
cardiomegaly with a promi-
nent left ventricular configu-
ration. There is pulmonary
vascular congestion and in-
terstitial edema. A central
venous catheter is noted (ar-
.. w_ ~~~~~~~~~~~~~~rows).
patient was desperately ill and had severely depressed ventricular function, I think this
procedure was an appropriate therapeutic intervention. His limiting clinical problem
was ventricular arrhythmias. In order to optimize arrhythmia therapy, a stable
hemodynamic state is essential. Moreover, the issue of potentially more definitive
therapeutic interventions such as aneurysectomy and coronary revascularization could
be addressed only after diagnostic cardiac catheterization. Without IABP support,
there would be an unreasonably high risk ofcomplications during angiography.
At catheterization, the presence of a large ventricular aneurysm was confirmed.
Coronary angiography demonstrated single-vessel coronary artery disease with a 90
percent residual stenosis in the proximal left anterior descending artery (LAD). The
patient's attending physicians elected to pursue medical management, perhaps because
they anticipated little benefit from surgical intervention in the absence ofdocumented
critical stenosesjeopardizing non-infarcted myocardium.
The patient was started on Amiodarone for control ofventricular tachycardia. The
IABP was successfully weaned, and the patient remained stable enough to allow
FIG. 2. A follow-up film obtained
the next day shows persistent conges-
tive heart failure. An endotracheal tube
and intra-aortic balloon pump (short
arrow) are in good position. A Swan-
Ganz catheter (open arrows) and trans-
venous pacer (long arrow) have been
inserted via a femoral approach.
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transfer to the cardiac step-down unit. I should mention that our cardiac electrophysi-
ology group has had remarkable success in bringing ventricular arrhythmias under
control in patients with severely depressed cardiac function. Although Amiodarone has
some direct myocardial depressant effects, the integrated effects ofall ofits pharmaco-
logic properties in patients with poor left ventricular function usually result in no
change in overall cardiac performance. Amiodarone can worsen heart block, although
the protocol makes no note of such an occurrence in this presumably well-monitored
patient.
After transfer to the step-down unit, the patient was apparently free of significant
arrhythmias on monitoring. He did have anemia and required packed red cell
transfusions. Anticoagulation therapy, which had been initiated for his deep venous
thrombosis, was therefore discontinued. No mention is made ofan anemia work-up.
On this new baseline of stable cardiac function, the patient collapsed six weeks
following his index infarction and could not be resuscitated. We can now consider the
differential diagnosis of late in-hospital death post-MI. Because the patient's demise
was rapid, I will assume that there was a severe degree of acute mechanical or
electrical cardiac dysfunction. In view of the patient's clinical course prior to death, I
think the discussion of the differential diagnosis can be focused on the following: (1)
ventricular fibrillation, (2) cardiogenic shock due to infarct extension, (3) cardiac
tamponade, (4) vascular collapse from acute blood loss, and (5) massive pulmonary
embolus.
Arrhythmias were a prominent feature in this patient's entire clinical course and
certainly deserve primary consideration as the etiology of his sudden demise. In-
hospital ventricular tachycardia and fibrillation occurring in monitored patients are
usually successfully converted. This patient's ventricular irritability appears to have
been well controlled on Amiodarone. For these reasons, I would consider the diagnosis
ofan arrhythmic event leading to death less likely than several other possibilities in the
differential.
Recurrent infarction or infarct extension with rapid hemodynamic decompensation
is unlikely on several grounds. First, the patient had only one significant lesion at
catheterization, and the size of his infarct suggests that all myocardium supported by
this coronary artery was irreversibly injured. Thus, recurrent ischemia with infarct
extension seems unlikely. Second, although patients with infarct extension following a
large MI may die of cardiogenic shock, the course tends to evolve over hours and not
minutes.
Several factors in this case lead us to consider the possibility of acute cardiac
tamponade. The protocol does not indicate whether the patient had a temporary
pacemaker in place at the time of death. If present, it may have perforated the right
ventricular wall, causing an acute hemopericardium with tamponade. Temporary
transvenous pacemaker perforations of the right ventricle are rather common, though
usually clinically silent. Apparently, adjacent pericardial tissue effectively contains the
myocardial rent and prevents severe hemodynamic deterioration. Anti-coagulated
patients are more likely to suffer rapid hemodynamic decompensation from perfora-
tion. Since this patient was not anti-coagulated, I will move on to other possibilities,
although pacemaker perforation remains an important diagnostic consideration.
For reasons discussed earlier, cardiac tamponade precipitated by acute rupture of a
ventricular free wall must be considered. Ruptures most typically occur between days
three and five following acute myocardial infarction, rarely occur after three weeks,
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and, in the absence of reinfarction or pseudoaneurysm formation, have not been
reported beyond one month following infarction [4]. Based on this simple fact, I would
not consider further the diagnosis ofcardiac rupture.
Although cardiac rupture is unlikely, rupture of a pseudoaneurysm is an interesting
consideration. A ventricular pseudoaneurysm represents a pericardial sac without
myocardial elements formed by a contained cardiac rupture. Pseudoaneurysms expand
over time and are said invariably to rupture. Characteristically, a pseudoaneurysm
has a narrow neck connecting it to the true ventricular chamber. There are other
angiographic features which usually help to distinguish pseudo from true ventricular
aneurysms. I will assume that our angiographers would have astutely picked up this
diagnosis at the time ofcardiac catheterization.
Leaving primary cardiac events as a cause of death, I would first consider the
category ofvascular collapse due to occult and sudden loss of blood. IABPs occasion-
ally cause life-threatening vascular trauma secondary to arterial perforation or
dissection. Such problems are usually evident at the time ofinsertion or within the first
24 hours. This patient died several days following discontinuation of IABP therapy,
and I will therefore discard this diagnosis. Acute gastrointestinal (GI) bleed is, of
course, a consideration in any critically ill patient. Indeed, this patient had received
blood transfusions to "maintain his hematocrit." Although occasionally catastrophic
death follows an acute GI bleed in patients with severe ventricular dysfunction, the
course is not typically abrupt and sudden as in this case.
Finally, we consider the possibility of pulmonary embolus, which not long ago was
one of the major causes of morbidity and mortality following myocardial infarction.
As already noted, this patient developed thromboembolic disease of his left lower
extremity, possibly initiated bydevices inserted through thefemoral venous system and
exacerbated by the long period of bed confinement. The patient received less than two
weeks of therapy for the deep venous thrombosis (DVT) before anticoagulation was
discontinued, clearly sub-optimal therapy. The significance ofclinically apparent deep
venous thromboses involving the large thigh veins is quite impressive. For instance, in
post-operative patients, if DVT of femoral or popliteal veins is diagnosed but not
treated, 40 percent of patients go on to have clinically apparent pulmonary emboli
[5].
We are thus left with this one compelling diagnostic consideration: massive
pulmonary embolus. Along with this patient's many cardiac-related problems, a
relativelystraightforward clinical problemdeveloped in parallel: deepvenous thrombo-
sis. Anticoagulation wasappropriately started but then terminated tooearly becauseof
suspected bleeding problems. Upon ambulation, thepatient probably dislodged a large
thrombus from the deep thigh veins, leading to massive pulmonary embolus and death
from acute right heart failure. I believe the patient died suddenly from this common
but infrequently diagnosed cause of in-hospital death which sadly and unexpectedly
interrupts the life ofotherwise successfully managed patients.
ClinicalDiagnosis
Massive pulmonary embolus
Pathologic Discussion
DR. STUART D. FLYNN (Assistant Professor ofPathology): As thoroughly discussed by
Dr. Lee, the patient presented today finally appeared to be improving after a
myocardial infarct and a complicated hospital course only to expire suddenly 45 days
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FIG. 3. An embolus (arrow) completely
occludes the right main pulmonary artery.
later. The occurrence of a patient dying suddenly in the setting of apparent clinical
improvement comprises a not insignificant percentage ofautopsies performed at large
medical centers. In this particular case, the probable cause ofdeath seems limited and
includes primarycardiac problems such asextensionofhis recentmyocardialinfarctor
rupture of the left ventricle wall or a secondary manifestation such as massive
pulmonary emboli.
Examination at autopsy was limited to the thorax only. The pleural cavities
contained a relatively small amount (200 ml) of serous fluid, with 50 ml of sero-
sanguineous fluid present in the pericardial sac. All of these serous surfaces were
smooth and glistening, without evidence of an exudate. The heart was slightly
enlarged, weighing 520 grams. Correlating with the clinical findings, there was
pronounced atherosclerosis of all three major coronary arteries with the left anterior
descending, left circumflex, and right coronary arteries exhibiting 90 percent, 65
percent, and 60 percent occlusion, respectively. Sectioning of the heart revealed
marked thinning ofthe anterior and lateral walls of the left ventricle, indicative of an
old infarct. Histologically, these areas were fibrotic with only a few residual myocytes
identified. These are features ofan infarct that occurred more than four weeks prior to
death, again corresponding with this patient's history.
Of greatest relevance to this patient's sudden demise, both the left and right main
pulmonary arteries were occluded by emboli (Fig. 3). In addition, several smaller
branches of the pulmonary arterial vasculature contained emboli, and there was an
associated recent right lower lobe infarct. Although the emboli probably originated in
the deep veins ofthe legs, no thrombi were palpated and dissection ofthese vessels was
not permitted.
Venous thromboemboli are a major cause of morbidity and mortality. It has been
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estimated that some 50,000 people per year die in the United States from pulmonary
emboli [6]. Since it is estimated that no more than one out of ten embolic events is
fatal, more than 500,000 patients probably experience pulmonary emboli annually.
Routine autopsy data reveal an incidence of pulmonary emboli of 20 to 30 percent,
whereas studies in which special attention is directed toward the pulmonary vascular
bed report an incidence as high as 60 percent [7].
The first description of massive occlusion of the pulmonary artery was reported by
Tulpius in 1641 (as cited by Liebow [8]). It became apparent in the nineteenth century
that the emboli were originating in the deep veins ofthe legs. Virchow emphasized the
importance of slowing of the bloodstream as a factor predisposing to thrombus
formation [9]. As it became clear in the 1930s and 1940s that the incidence of
pulmonary emboli was increasing dramatically, attention began to be focused on how
best to diagnose these thromboembolic events [10].
It has been estimated that 95 percent ofall pulmonary emboli arise from thrombi in
the deep venous system ofthe lower extremities and that five million patients per year
in the United States develop an episodeofdeepvenous thrombosis [6]. Autopsy studies
have revealed that early microscopic thrombi were found in the pockets ofvalve cusps,
in saccules in the vein wall, and at vein junctions [11]. Six primary sites have been
described: (1) the iliac vein, especially the external iliac vein; (2) the common femoral
vein; (3) the termination ofthe deep femoral vein, usually at a valve cusp at its ostium;
(4) the popliteal vein, distal to the adductor ring and at a relatively large valve; (5) the
posterior tibial veins; and (6) the intramuscular veins of the calf, especially the soleal
veins. Although thrombi within veins of the calf muscles are most common, many
significant pulmonary emboli arise from thrombi within the large deep veins of the
legs, especially those above the knee [12]. Thrombosis at one site is independent of
thrombosis elsewhere, and it is often a bilateral process.
Finally, there are several well-defined risk factors associated with the development
of venous thromboembolism [13]; these include surgical trauma, immobilization,
malignant disease, obesity, age (older than 40 years), myocardial infarct, and heart
failure, the last three of which pertain to this patient. It has been estimated that fatal
pulmonary emboli develop post-operatively in 0.1 percent to 0.8 percent of patients
who undergo elective hip surgery, and 4 percent to 7 percent of patients who have
emergency hip surgery [13]. Like this patient, the majority of patients who die of
pulmonary emboli do so with little or no warning. Two-thirds of patients who die
succumb within 30 minutes ofthe acute event, and, in many cases, the diagnosis is not
established until after the patient's death.
Pathological Diagnosis
Sudden death secondary to massive pulmonary emboli; large left ventricle myocar-
dial infarct
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